Weaver C. Barksdale & Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$111K Buy
7,352
+1,235
+20% +$17.4K 0.12% 73
2017
Q3
$101K Buy
6,117
+573
+10% +$9.72K 0.11% 72
2017
Q2
$107K Sell
5,544
-111
-2% -$1.94K 0.12% 70
2017
Q1
$100K Sell
5,655
-1,959
-26% -$36.3K 0.12% 73
2016
Q4
$113K Buy
7,614
+3,635
+91% +$65.2K 0.18% 65
2016
Q3
$90K Buy
3,979
+1,022
+35% +$26.6K 0.15% 68
2016
Q2
$82K Buy
+2,957
New +$87.4K 0.14% 66
2014
Q1
– Sell
-44,700
Closed -$1.88M – 562
2013
Q4
$1.88M Hold
44,700
– – 1.58% 29
2013
Q3
$1.84M Buy
+44,700
New +$1.87M 1.69% 26

Other funds holding THC

Weaver C. Barksdale & Associates's THC Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Tenet Healthcare (THC) stake by 20% in Q4 2017, buying an estimated $17.4K and bringing the position to 7,352 shares worth $111K. The position accounts for 0.12% of the portfolio, ranked #73.

Weaver C. Barksdale & Associates first reported a position in THC in Q3 2013 and has held it in 9 quarters since. The position peaked at $1.88M in Q4 2013. 234 funds tracked by Wall St. Rank hold THC as of Q4 2017.

  • Weaver C. Barksdale & Associates held 7,352 shares of Tenet Healthcare worth $111K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 1,235 Tenet Healthcare shares in Q4 2017, an estimated $17.4K.
  • Tenet Healthcare made up 0.12% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #73 holding.
  • Weaver C. Barksdale & Associates first reported a position in Tenet Healthcare in Q3 2013 and has held it in 9 quarters since.
  • Weaver C. Barksdale & Associates's Tenet Healthcare position peaked at $1.88M in Q4 2013.
  • 234 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.